Dr Kayleigh Mason PhD

Research Associate

Full contact details
View graph of relations

Publications

  1. 2020
  2. Accepted/In press
  3. E-pub ahead of print

    Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic

    Secure-AD, PsoPROTECT study groups, 29 Apr 2020, In : The British journal of dermatology.

    Research output: Contribution to journalLetterpeer-review

  4. E-pub ahead of print
  5. Published
  6. Published

    Risk of Major Cardiovascular Events in Patients with Psoriasis Receiving Biologic Therapies: a Prospective Cohort Study

    Rungapiromnan, W., Mason, K. J., Lunt, M., Mcelhone, K., Burden, A. D., Rutter, M. K., Warren, R. B., Griffiths, C. E. M. & Ashcroft, D. M., 2020, In : Journal of the European Academy of Dermatology and Venereology. 34, p. 769-778 10 p.

    Research output: Contribution to journalArticlepeer-review

  7. 2019
  8. Published

    HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

    BADBIR Study Group, Jun 2019, In : The Journal of allergy and clinical immunology. 143, 6, p. 2120-2130 11 p.

    Research output: Contribution to journalArticlepeer-review

  9. Accepted/In press

    Real-world drug discontinuation of acitretin (ACI), ciclosporin (CsA), fumaric acid esters (FAE) and methotrexate (MTX) in patients with moderate-severe psoriasis

    Mason, K., Smith, C. H., Williams, S., Lunt, M., Yiu, Z., Mcelhone, K., Ashcroft, D., Kleyn, C., Jabbar-Lopez, Z. K., Owen, C. M., Stocken, D. D., Wilson, N., Warren, R. B., Griffiths, CEM. & Reynolds, N. J., 9 May 2019, (Accepted/In press).

    Research output: Contribution to conferenceAbstractpeer-review

  10. E-pub ahead of print

    A Standardisation Approach to Compare Treatment Safety and Effectiveness Outcomes between Clinical Trials and Real World Populations in Psoriasis

    BADBIR Study Group, 1 Mar 2019, In : The British journal of dermatology.

    Research output: Contribution to journalArticlepeer-review

  11. Published

    HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

    Dand, N., Duckworth, M., Baudry, D., Russell, A., Curtis, C. J., Lee, S. H., Evans, I., Mason, K., Al-Sharqi, A., Becher, G., Burden, A. D., Goodwin, R., McKenna, K., Murphy, R., Perera, G., Rotarescu, R., Wahie, S., Wright, A., Reynolds, N. J., Warren, R. & 7 others, Griffiths, CEM., Smith, C. H., Simpson, M. A., Barker, J. N. W. N., The BADBIR Study Group, The BSTOP Study Group & The PSORT Consortium, 2019, In : Journal of Allergy and Clinical Immunology.

    Research output: Contribution to journalArticlepeer-review

  12. Published

    Persistence and Effectiveness of Non-Biologic Systemic Therapies for Moderate-Severe Psoriasis in Adults: a Systematic Review

    Mason, K., Williams, S., Yiu, Z., McElhone, K., Ashcroft, D., Kleyn, C., Jabbar-Lopez, Z. K., Owen, C. M., Reynolds, N. J., Smith, C. H., Wilson, N., Warren, R. & Griffiths, CEM., 2019, In : Br J Dermatol. 181, 2, p. 256-264

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 4 Next